Phase 3 Stomach Cancer Trial, Recruiting NCT06755554 Sponsor: Ukrainian Society of Clinical Oncology Condition: Stomach Cancer
Back to Stomach Cancer

Phase 3 Stomach Cancer Trial, Recruiting

NCT06755554
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The cancer has spread to a certain extent within the stomach area, but has not spread to distant parts of the body (confirm with trial site for exact staging details)
  • You are between 18 and 80 years old
  • You are male or female
  • You are generally able to carry out daily activities with little or no limitation due to your illness
  • Your cancer type is adenocarcinoma of the stomach (a specific type of stomach cancer), of any subtype or grade
  • The cancer is located in a specific part of the stomach, including the upper, middle, or lower sections
  • The cancer has not grown into surrounding organs or structures
  • You have not had any other cancer diagnosis in the last 5 years
  • You have not previously had chemotherapy, surgery, or radiation for another cancer (pre-surgery chemotherapy specifically for stomach cancer may be acceptable)
  • You do not have serious other health conditions that would prevent keyhole (laparoscopic) surgery

Who may not be able to join:

  • The cancer has already spread to distant parts of the body (such as other organs)
  • Your daily activities are significantly limited or you are unable to care for yourself due to illness
  • You are under 18 or over 80 years old
  • You have serious other health conditions that put you at high surgical risk (confirm with trial site)
  • You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +380638760185

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Ukrainian Society of Clinical Oncology
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇺🇦 Ukraine

Primary endpoints

Investigation of the average number of lymph nodes removed during lymph node dissection using indocyanine green

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov